Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
WCLC 2016 – Lung Cancer
Screening for Lung Cancer
By
Dr. Edward Garon
Lung Cancer
,
WCLC 2016 – Lung Cancer
Videos
Dr. Edward Garon talks about the best approaches for screening patients for lung cancer.
Read Article
Smoking Cessation and Lung Cancer
By
Dr. Edward Garon
Lung Cancer
,
WCLC 2016 – Lung Cancer
Videos
Dr. Edward Garon discusses the importance of smoking cessation programs for patients diagnosed with lung cancer.
Read Article
Common Concerns in Managing Patients with NSCLC
By
Dr. Edward Garon
Lung Cancer
,
WCLC 2016 – Lung Cancer
Videos
Dr Edward Garon provides an overview of the main concerns he has in managing patients with NSCLC, citing pseudoprogression as one of the biggest misconceptions.
Read Article
Improving Lung Cancer Screening
Lung Cancer
,
WCLC 2016 – Lung Cancer
Videos
Dr Suresh Ramalingam discusses the importance of screening for lung cancer and identifies the ideal patients to target for screening.
Read Article
Individualizing Treatment for Lung Cancer
Lung Cancer
,
WCLC 2016 – Lung Cancer
Videos
Dr Suresh Ramalingam examines the factors he considers when making treatment decisions for his patients.
Read Article
What's Ahead for Treating NSCLC
By
Dr. Edward Garon
Lung Cancer
,
WCLC 2016 – Lung Cancer
Videos
Although Dr Edward Garon feels the future of NSCLC is unclear, he cites how treatment has progressed over the years and wonders how immunotherapies and combination therapies will impact treatment.
Read Article
Plenary Session 2B: Tobacco Control and Smoking Cessation and Prevention
WCLC 2016 – Lung Cancer
Conference Correspondent
Tobacco use is a preventable cause of cancer. Data suggest that approximately 33% of all cancers, including lung, head and neck, esophageal, pancreas, colon, and some types of leukemia, are caused by tobacco use. This session will review the relationships between smoking, free trade, industry regulation, and global public health.
Read Article
Mini Oral Session 1: Improvement and Implementation of Lung Cancer Screening
WCLC 2016 – Lung Cancer
Conference Correspondent
Early detection of lung cancer enhances patient survival. However, the value of specific screening programs is affected by multiple factors, including patient selection methods, triage algorithms, and imaging technology. This oral session includes presentations of novel approaches to the detection of lung cancer.
Read Article
Plenary Session 4A: Advances in Therapy for Metastatic Non–Small-Cell Lung Cancer (NSCLC)
WCLC 2016 – Lung Cancer
Conference Correspondent
This plenary session includes 4 presentations that describe the role of PD-L1 testing and immuno-oncology agents in the treatment of patients with first-line and relapsed NSCLC. All of these abstracts are embargoed until December 7, 2016.
Read Article
Plenary Session 5: Reflections from Giants on Milestones in the Treatment Advances in Lung Cancer—Translational Lung Cancer Research
WCLC 2016 – Lung Cancer
Conference Correspondent
Association of a survival benefit with chemotherapy use for non–small-cell lung cancer (NSCLC) was observed only after the development of cisplatin and platinum doublets. Recent therapeutic advancements in NSCLC and other solid tumors have revolved around the development of immunotherapies that inhibit immune checkpoints, as well as drugs that target driver mutations.
Read Article
Page 2 of 4
1
2
3
4
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Navigating the Complex Landscape of Oral Cancer Medication
2.
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
3.
New NCCN Guidelines for CLL/SLL Include Second-Generation BTK Inhibitors
Wayne Kuznar
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma